title: [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
abstract: According to the World Health Organization, it is recorded steady growth of the number of chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD), in recent years. As an independent nosological entity, NAFLD is one of the risk factors for cardiovascular diseases, associated with abdominal-visceral obesity, peripheral insulin resistance (IR), and is regarded as the hepatic component of Metabolic syndrome (MS). Nowadays there are no generally accepted national standards for diagnosis and treatment of NAFLD for physicians, gen- eral practitioners, gastroenterologists in Russia. This was the essential reason in their development. The main reason of The guidelines development is the absence of generally accepted national standards for diagnosis and treatment of NAFLD for physicians, general practitioners, gastroenterologists in Russia. These guidelines are based on the global and local data of treatment experience of NAFLD, recently published in reviews, analytical studies in the literature. Guidelines are intended for physicians, general practitioners, gastroenterologists and contain the description of the preferred approaches to the provision of diagnostic, curative and preventive care of patients NAFLD. The quality of recommendations was grading according to the GRADE approach.
authors.forename: L B
authors.initials: LB
authors.lastname: Lazebnik
authors.forename: V G
authors.initials: VG
authors.lastname: Radchenko
authors.forename: E V
authors.initials: EV
authors.lastname: Golovanova
authors.forename: L A
authors.initials: LA
authors.lastname: Zvenigorodskaya
authors.forename: Yu V
authors.initials: YV
authors.lastname: Konev
authors.forename: P V
authors.initials: PV
authors.lastname: Seliverstov
authors.forename: S I
authors.initials: SI
authors.lastname: Sitkin
authors.forename: E I
authors.initials: EI
authors.lastname: Tkachenko
authors.forename: E K
authors.initials: EK
authors.lastname: Aylamazayn
authors.forename: N N
authors.initials: NN
authors.lastname: Vlasov
authors.forename: E A
authors.initials: EA
authors.lastname: Kornienko
authors.forename: V P
authors.initials: VP
authors.lastname: Novikova
authors.forename: L P
authors.initials: LP
authors.lastname: Horoshinina
authors.forename: N V
authors.initials: NV
authors.lastname: Zhestkova
authors.forename: L S
authors.initials: LS
authors.lastname: Oreshko
authors.forename: O P
authors.initials: OP
authors.lastname: Dudanova
authors.forename: V P
authors.initials: VP
authors.lastname: Dobrica
authors.forename: L V
authors.initials: LV
authors.lastname: Turyeva
authors.forename: O V
authors.initials: OV
authors.lastname: Tirikova
authors.forename: N M
authors.initials: NM
authors.lastname: Kozlova
authors.forename: S M
authors.initials: SM
authors.lastname: Eliseev
authors.forename: R R
authors.initials: RR
authors.lastname: Gumerov
authors.forename: E V
authors.initials: EV
authors.lastname: Vencak
mesh_terms: D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy*; D017410:Practice Guidelines as Topic